CASEIF II is a private equity fund of 35 million dollars for growth stage companies in the Central American region. SMEs in the region generally lack access to financing and long term capital, the basis for their growth. CASEIF II is committed to providing long term capital needs to these companies and to playing a demonstration role. It also aims at improving transparency and governance within its investees.

BIO has committed a $ 5 million equity investment in CASEIF II. Other partners include the Multilateral Investment Fund (MIF) of the Inter-American Development Bank (IADB), the Norwegian Investment Fund for Development (Norfund), the Swiss Investment Fund for Emerging Markets (SIFEM), the Finnish Fund for Industrial Cooperation (Finnfund), the Andean Investment Corporation (CAF) and Latin American Financial Services (LAFISE).


BIO subsidized a Technical Assistance Facility for CASEIF II.

  • Investment amount (€):

    USD 5 million

    Registered offices: Bahamas Beneficiary countries: Costa Rica, El Salvador, Honduras, Nicaragua, Panama

  • Contract signature :


  • Nature of intervention :


  • Development impacts :

    • 1 — providing long term capital needs to SMEs
    • 2 — improving transparency and governance in the investee companies
    • 3 — job creation (direct and indirect)